Mannkind (MNKD) Stock Price
$5.76 1.8%
to add to portfolio
AI Score

-
Alternative
4 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Mannkind, AI stock picks, stock alerts and much more.
MNKD AI Stock Analysis
AI stock analysis for MNKD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mannkind (MNKD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Mannkind (MNKD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mannkind (MNKD), currently trading at $5.76, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MNKD

-
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.
-
Symbol
MNKD
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.6B
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
MNKD Alternative Data
Web Traffic
Mannkind receives an estimated 15517 monthly visitors to mannkindcorp.com.
-
Web Traffic
15517
-
Change from Previous Month
23.4%
-
3 Month Change
29.4%
-
YoY Change
29.4%
Reddit Mentions
Mannkind has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
News Mentions
Mannkind was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Twitter Followers
Mannkind has 2,763 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
2763
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Facebook Engagement
Mannkind has engaged 45 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
45
-
Daily Change
12.5%
-
1 Month Change
28.6%
-
3 Month Change
73.1%
-
YoY Change
73.1%
Instagram Followers
Mannkind has 1,127 Instagram Followers on its main Instagram account, up by 1.2% over the last month.
-
Instagram Followers
1127
-
Daily Change
0.4%
-
1 Month Change
1.2%
-
3 Month Change
2.7%
-
YoY Change
2.7%
Youtube Subscribers
Mannkind has 272 subscribers on its main Youtube channel, up by 0.4% over the last month.
-
Youtube Subscribers
272
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
13,800 are following Mannkind on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
13800
-
Daily Change
0.1%
-
1 Month Change
2.1%
-
3 Month Change
6%
Job Postings
Mannkind currenly has an estimated 34 open job postings, up by 41.7% over the last month.
-
Job Postings
34
-
Daily Change
0%
-
1 Month Change
41.7%
-
3 Month Change
126.7%
-
YoY Change
126.7%
LinkedIn Employees
According to LinkedIn, Mannkind has 563 employees, up by 0.9% over the last month.
-
LinkedIn Employees
563
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Business Outlook
-
Business Outlook
82
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
MNKD Financials
MNKD Key Metrics
-
Total Revenue
$70.1M
-
Net Income
$11.6M
-
Earnings per Share
$0.042
-
Free cash flow
$7.9M
-
EBITDA
$12.8M
-
EBITDA Ratio
0.18208
-
Total Assets
$464.2M
MNKD 2-year Revenue & Income
MNKD 2-year Free Cash Flow
MNKD Technicals
MNKD SMA
MNKD RSI
FAQ
What's the current price of Mannkind (MNKD) Stock?
The price of an Mannkind (MNKD) share is $5.76.
What's the market cap of Mannkind?
The current market cap of Mannkind is 1.6B.
Should I buy or sell MNKD?
Mannkind shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Mannkind is better viewed as a hold or accumulate position while waiting for further developments.
Is Mannkind a good investment?
The current analysis of Mannkind's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Mannkind's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Mannkind (MNKD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Mannkind stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Mannkind (MNKD) that investors often compare it to?
Mannkind (MNKD) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Mannkind's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mannkind's stock price to be around $5.59 in 2026. Starting from the current price of $5.76, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy Mannkind (MNKD) Stock?
Mannkind stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mannkind shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.